Literature DB >> 17389012

Low frequency of the disease-associated DRB1*15-DQB1*06 haplotype may contribute to the low prevalence of multiple sclerosis in Sami.

H F Harbo1, E Utsi, A R Lorentzen, M T Kampman, E G Celius, K-M Myhr, B A Lie, S I Mellgren, E Thorsby.   

Abstract

This study confirms a low frequency of multiple sclerosis (MS) among Sami. Only 12 Sami with a diagnosis of MS were identified in the Norwegian Sami population, which represents a significantly lower prevalence of MS in Sami (30/10(5)) compared with other Norwegians (73-164/10(5)). The clinical characteristics as well as the results of human leukocyte antigen (HLA)-DRB1 and -DQB1 typing of the Sami MS patients are reported, showing that three (27%) of the Sami MS patients carried the MS-associated HLA-DRB1*15-DQB1*06 haplotype. Interestingly, the DRB1*15-DQB1*06 haplotype had a significantly reduced frequency among Sami controls (0.086) compared with non-Sami Norwegian controls (0.163) (P(corrected) = 0.015). The low frequency of the disease-associated DRB1*15-DQB1*06 haplotype in the Sami population may contribute to the low prevalence of MS in Sami, in addition to other yet unidentified genetic and environmental factors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17389012     DOI: 10.1111/j.1399-0039.2007.00803.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  11 in total

Review 1.  The genetics of multiple sclerosis: an up-to-date review.

Authors:  Pierre-Antoine Gourraud; Hanne F Harbo; Stephen L Hauser; Sergio E Baranzini
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

2.  Alaska, multiple sclerosis, and the vitamin D hypothesis.

Authors:  Trygve Holmøy; Margitta T Kampman
Journal:  J Neurol       Date:  2009-10-28       Impact factor: 4.849

3.  Association of UV radiation with multiple sclerosis prevalence and sex ratio in France.

Authors:  S-M Orton; L Wald; C Confavreux; S Vukusic; J P Krohn; S V Ramagopalan; B M Herrera; A D Sadovnick; G C Ebers
Journal:  Neurology       Date:  2011-02-01       Impact factor: 9.910

4.  Sex ratio of multiple sclerosis in persons born from 1930 to 1979 and its relation to latitude in Norway.

Authors:  Margitta T Kampman; Jan Harald Aarseth; Nina Grytten; Espen Benjaminsen; Elisabeth Gulowsen Celius; Ole Petter Dahl; Trygve Holmøy; Kristin Løken-Amsrud; Rune Midgard; Kjell-Morten Myhr; Geir Risberg; Anita Vatne; Oivind Torkildsen
Journal:  J Neurol       Date:  2013-01-06       Impact factor: 4.849

Review 5.  What is known about the health and living conditions of the indigenous people of northern Scandinavia, the Sami?

Authors:  Per Sjölander
Journal:  Glob Health Action       Date:  2011-10-14       Impact factor: 2.640

Review 6.  Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades.

Authors:  N Grytten; Ø Torkildsen; K-M Myhr
Journal:  Acta Neurol Scand       Date:  2015       Impact factor: 3.209

Review 7.  Incidence and prevalence of multiple sclerosis in Europe: a systematic review.

Authors:  Elaine Kingwell; James J Marriott; Nathalie Jetté; Tamara Pringsheim; Naila Makhani; Sarah A Morrow; John D Fisk; Charity Evans; Sarah Gabrielle Béland; Sophie Kulaga; Jonathan Dykeman; Christina Wolfson; Marcus W Koch; Ruth Ann Marrie
Journal:  BMC Neurol       Date:  2013-09-26       Impact factor: 2.474

8.  Environmental factors and multiple sclerosis severity: a descriptive study.

Authors:  Daniele Mandia; Ottavia E Ferraro; Guido Nosari; Cristina Montomoli; Elisabetta Zardini; Roberto Bergamaschi
Journal:  Int J Environ Res Public Health       Date:  2014-06-19       Impact factor: 3.390

9.  Multiple sclerosis in the far north--incidence and prevalence in Nordland County, Norway, 1970-2010.

Authors:  Espen Benjaminsen; Johnny Olavsen; Merethe Karlberg; Karl B Alstadhaug
Journal:  BMC Neurol       Date:  2014-12-04       Impact factor: 2.474

Review 10.  The influence of sodium on pathophysiology of multiple sclerosis.

Authors:  Jacek Zostawa; Jowita Adamczyk; Paweł Sowa; Monika Adamczyk-Sowa
Journal:  Neurol Sci       Date:  2017-01-11       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.